These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Assessment of left ventricular systolic and diastolic functions in children with merosin-positive congenital muscular dystrophy. Ceviz N; Alehan F; Alehan D; Ozme S; Akçören Z; Kale G; Topaloglu H Int J Cardiol; 2003 Feb; 87(2-3):129-33; discussion 133-4. PubMed ID: 12559529 [TBL] [Abstract][Full Text] [Related]
63. Muscle-eye-brain disease and Fukuyama type congenital muscular dystrophy are not allelic. Ranta S; Pihko H; Santavuori P; Tahvanainen E; de la Chapelle A Neuromuscul Disord; 1995 May; 5(3):221-5. PubMed ID: 7633187 [TBL] [Abstract][Full Text] [Related]
64. Broader clinical spectrum of Fukuyama-type congenital muscular dystrophy manifested by haplotype analysis. Yoshioka M; Toda T; Kuroki S; Hamano K J Child Neurol; 1999 Nov; 14(11):711-5. PubMed ID: 10593547 [TBL] [Abstract][Full Text] [Related]
65. CT of primary muscle diseases. Jiddane M; Gastaut JL; Pellissier JF; Pouget J; Serratrice G; Salamon G AJNR Am J Neuroradiol; 1983; 4(3):773-6. PubMed ID: 6410854 [TBL] [Abstract][Full Text] [Related]
67. Ocular manifestations of congenital muscular dystrophy (Fukuyama type). Chijiiwa T; Nishimura M; Inomata H; Yamana T; Narazaki O; Kurokawa T Ann Ophthalmol; 1983 Oct; 15(10):921-3, 926-8. PubMed ID: 6651132 [TBL] [Abstract][Full Text] [Related]
68. [Evaluation of cranial CT findings of patients with muscular dystrophy: with a reference to cerebral vascular disease and cardiac complications]. Konagaya M; Sakai M; Kuru S; Kato T; Yasuma F; Matsuoka Y No To Shinkei; 1999 Jul; 51(7):621-6. PubMed ID: 10457950 [TBL] [Abstract][Full Text] [Related]
69. [Congenital muscular dystrophy with leukoencephalopathy]. Aver'ianov IuN Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):27-9. PubMed ID: 8154212 [TBL] [Abstract][Full Text] [Related]
74. [A case of congenital muscular dystrophy (Fukuyama type) complicated by cystinuria]. Satoh M; Shimizu N; Tazawa M; Taguchi T; Sekiguchi M No To Hattatsu; 1986 Sep; 18(5):422-3. PubMed ID: 3756027 [No Abstract] [Full Text] [Related]
75. Adenylate cyclase in Duchenne and Fukuyama type muscular dystrophy. Takahashi K; Takao H; Takai T Kobe J Med Sci; 1978 Dec; 24(4):193-8. PubMed ID: 739733 [No Abstract] [Full Text] [Related]
76. Congenital muscular dystrophy with distinct CNS involvement. Olive M; Sirvent J; Ferrer I Neuropediatrics; 1994 Feb; 25(1):48-50. PubMed ID: 8208353 [TBL] [Abstract][Full Text] [Related]
77. [Fukuyama type congenital muscular dystrophy (cerebro-muscular disease). A case report]. García-Cruz A; Pavón-Heredia A; Ortega-Pérez M; Estupiñán B; Hernández-Lara J; Infante E Rev Neurol; 2000 Aug 16-31; 31(4):398-400. PubMed ID: 11008300 [No Abstract] [Full Text] [Related]
78. Cerebro-ocular dysplasia and muscular dystrophy: report of two cases. Federico A; Dotti MT; Malandrini A; Guazzi GC; Hayek G; Simonati A; Rizzuto N; Toti P Neuropediatrics; 1988 May; 19(2):109-12. PubMed ID: 3374764 [TBL] [Abstract][Full Text] [Related]
79. Progression of muscular dystrophy assessed by computed tomography. Stern LM; Caudrey DJ; Perrett LV; Boldt DW Dev Med Child Neurol; 1984 Oct; 26(5):569-73. PubMed ID: 6510558 [TBL] [Abstract][Full Text] [Related]
80. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Philpot J; Cowan F; Pennock J; Sewry C; Dubowitz V; Bydder G; Muntoni F Neuromuscul Disord; 1999 Mar; 9(2):81-5. PubMed ID: 10220862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]